Rxo (RXO) Receivables - Other (2021 - 2025)

Rxo (RXO) has 5 years of Receivables - Other data on file, last reported at $26.0 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables - Other rose 52.94% year-over-year to $26.0 million; the trailing twelve-month figure through Dec 2025 stood at $26.0 million (up 52.94% YoY), and the FY2025 full-year result was $26.0 million, up 52.94% from the prior year.
• Receivables - Other for Q4 2025 stood at $26.0 million, up from $17.0 million in the prior quarter.
• Across five years, Receivables - Other topped out at $26.0 million in Q4 2025 and bottomed at $5.0 million in Q3 2022.
• The 5-year median for Receivables - Other is $11.0 million (2023), against an average of $13.8 million.
• The widest annual swing landed in 2024, when Receivables - Other surged 54.55%; it then surged 52.94% in 2025.
• A 5-year view of Receivables - Other shows it stood at $10.0 million in 2021, then sank by 50.0% to $5.0 million in 2022, then surged by 120.0% to $11.0 million in 2023, then soared by 54.55% to $17.0 million in 2024, then jumped by 52.94% to $26.0 million in 2025.
• The last three Receivables - Other figures came in at $26.0 million (Q4 2025), $17.0 million (Q4 2024), and $11.0 million (Q4 2023), per Business Quant data.

Peer Comparison